Pieters, R H <br/><br/>
The thymus atrophy-inducing organotin compound DBTC inhibits the binding of thymocytes to thymic epithelial cells.  [electronic resource] 

 -  International journal of immunopharmacology  Apr 1995 
 - 329-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0192-0561 
<br/><br/><label>Standard No.: </label>10.1016/0192-0561(94)00103-u  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atrophy<br/>CD2 Antigens--metabolism<br/>Cell Adhesion--drug effects<br/>Cell Line<br/>Depression, Chemical<br/>Dextran Sulfate--pharmacology<br/>Epithelium--metabolism<br/>Histocompatibility Antigens Class II--immunology<br/>Microscopy, Electron<br/>Organotin Compounds--pharmacology<br/>Rats<br/>T-Lymphocyte Subsets--drug effects<br/>Thy-1 Antigens--metabolism<br/>Thymus Gland--drug effects